Age and comedications influence levetiracetam pharmacokinetics in children

Pediatric Neurology

Volumn 43, Issue 4, 2010, Pages 231-235

  Dahlin, Maria G ^a   Wide, Katarina ^a   Ohman, Inger ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADOLESCENT; AGE; ARTICLE; CHILD; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; EPILEPSY; EVENING DOSAGE; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MORNING DOSAGE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; STEADY STATE;

ADOLESCENT; AGE FACTORS; ANTICONVULSANTS; CARBAMAZEPINE; CHILD; CHILD, PRESCHOOL; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; METABOLIC CLEARANCE RATE; PHENYTOIN; PIRACETAM; RETROSPECTIVE STUDIES; TRIAZINES; VALPROIC ACID;

EID: 77956589604     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2010.05.008     Document Type: Article

References (21)

1. T. Betts, T. Waegemans, and P. Crawford A multicentre, double-blind, randomized, parallel group study to evaluate the tolerability and efficacy of two oral doses of levetiracetam, 2000 mg daily and 4000 mg daily, without titration in patients with refractory epilepsy Seizure 9 2000 80 87
2. J.J. Cereghino, V. Biton, B. Abou-Khalil, F. Dreifuss, L.J. Gauer, and I. Leppik Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial Neurology 25 2000 236 242
3. T.A. Glauser, R. Ayala, R.D. Elterman N159 Study Group Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures Neurology 13 2006 1654 1660
4. P.N. Patsalos Pharmacokinetic profile of levetiracetam: Toward ideal pharmacokinetics Pharmakol Ther 85 2000 77 85
5. J.M. Nicolas, P. Collart, and B. Gerin In vitro evaluation of potential drug interactions with levetiracetam, a new antiepileptic agent Drug Metab Dispos 27 1999 250 254
6. M. Contin, F. Albani, R. Riva, and A. Baruzzi Levetiracetam therapeutic monitoring in patients with epilepsy: Effect of concomitant antiepileptic drugs Ther Drug Monit 26 2004 375 379
7. L.J. Hirsch, H. Arif, and R. Buchsbaum Effect of age and comedication on levetiracetam pharmacokinetics and tolerability Epilepsia 48 2007 1351 1359
8. J.M. Pellock, T.A. Glauser, and E.M. Bebin Pharmacokinetic study of levetiracetam in children Epilepsia 42 2001 1574 1579
9. T.A. Glauser, W.G. Mitchell, and A. Weinstock Pharmacokinetics of levetiracetam in infants and young children with epilepsy Epilepsia 48 2007 1117 1122
10. N.B. Fountain, J.A. Conry, and I. Rodríguez-Leyva Prospective assessment of levetiracetam pharmacokinetics during dose escalation in 4- to 12-year-old children with partial-onset seizures on concomitant carbamazepine or valproate Epilepsy Res 74 2007 60 69
11. E. Perucca Clinical pharmacokinetics of new-generation antiepileptic drugs at the extremes of age Clin Pharmacokinet 45 2006 351 363
12. P.B. Pennell, D.J. Newport, Z.N. Stowe, S.L. Helmers, J.Q. Montgomery, and T.R. Henry The impact of pregnancy and childbirth on the metabolism of lamotrigine Neurology 27 2004 292 295
13. D. Weintraub, R. Buchsbaum, S.R. Resor Jr., and L.J. Hirsch Effect of antiepileptic drug comedication on lamotrigine clearance Arch Neurol 62 2005 1432 1436
14. N. Toublanc, M.L. Sargentini-Maier, B. Lacroix, P. Jacqmin, and A. Stockis Retrospective population pharmacokinetic analysis of levetiracetam in children and adolescents with epilepsy: Dosing recommendations Clin Pharmacokinet 47 2008 333 341
15. S. Chhun, V. Jullien, E. Rey, O. Dulac, C. Chiron, and G. Pons Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy Epilepsia 50 2009 1150 1157
16. E. Perucca, B.E. Gidal, and E. Balts Effects of antiepileptic comedication on levetiracetam pharmacokinetics: A pooled analysis of data from randomized adjunctive therapy trials Epilepsy Res 53 2003 47 56
17. G. Tybring, C. von Bahr, L. Bertilsson, H. Collste, H. Glaumann, and M. Solbrand Metabolism of carbamazepine and its epoxide metabolite in human and rat liver in vitro Drug Metab Dispos 9 1981 561 564
18. B. Lundgren, and J.W. DePierre Proliferation of peroxisomes and induction of cytosolic and microsomal epoxide hydrolases in different strains of mice and rats after dietary treatment with clofibrate Xenobiotica 19 1989 867 881
19. T. Tomson, R. Palm, and K. Källén Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation Epilepsia 48 2007 1111 1116
20. A.A. Westin, A. Reimers, G. Helde, K.O. Nakken, and E. Brodtkorb Serum concentration/dose ratio of levetiracetam before, during and after pregnancy Seizure 17 2008 192 198
21. C. Otoul, H. De Smedt, and A. Stockis Lack of pharmacokinetic interaction of levetiracetam on carbamazepine, valproic acid, topiramate, and lamotrigine in children with epilepsy Epilepsia 48 2007 2111 2115